Novo Nordisk A/S: Novo Nordisk successfully completes phase 1b/2a trial with subcutaneous amycretin in people with overweight or obesity
Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly ...
Taean Wind Power Secures Fixed-Price Offtake Contract To Develop Offshore Wind Project In Korea
South Korea has significant potential for offshore wind and is one of the most promising markets in Asia Pacific, with an ambitious target of 14.3GW installed capacity by 2030. The country has pledged ...
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; January 23, 2025 – (Nasdaq: GMAB) announced today that the Board decided to grant 4,903 restricted stock units and 5,289 warrants to employees of the Company ...
Netcompany - Transactions in connection with share buyback programme
Company announcement No. 04/2025 23 January 2025 Transactions in connection with share buyback programmeOn 31 October 2024, ...
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...
Genmab A/S: Genmab Announces Net Sales of DARZALEX (daratumumab) for 2024
Company Announcement Net sales of DARZALEX® in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAG ...
Danske Bank A/S, transactions by persons discharging managerial responsibilities
Notification no. 6/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back ...
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
Company AnnouncementNet sales of DARZALEX® in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson & ...
crypto2community4d
Virtune Lists Finland’s First Crypto ETPs on Nasdaq Helsinki
Virtune lists Finland's first crypto ETPs on Nasdaq Helsinki offering safe access to crypto investments in euros through ...
Nasdaq Helsinki launches a new segment for ETN products
Nasdaq (Nasdaq: NDAQ) today announced that Nasdaq Helsinki launches a new segment for ETN (Exchange Traded Notes) products. ETNs are exchange listed debt instruments issued ...
cBrain A/S: cBrain raises expected 2024 EBT margin to 30-32%
Company Announcement no. 01/2025 cBrain raises expected 2024 EBT margin to 30-32%Copenhagen, January 20, 2025For the year 2024, cBrain (NASDAQ: CBRAIN) has forecasted revenue growth of 10-15% and ...